RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
75 hedge funds and large institutions have $632M invested in Rubius Therapeutics, Inc in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3% less call options, than puts
Call options by funds: $758K | Put options by funds: $785K
49% less capital invested
Capital invested by funds: $1.23B → $632M (-$599M)
Holders
75
Holding in Top 10
3
Calls
$758K
Puts
$785K
Top Buyers
| 1 | +$3.14M | |
| 2 | +$3.01M | |
| 3 | +$2.37M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.92M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$1.69M |
Top Sellers
| 1 | -$1.59M | |
| 2 | -$850K | |
| 3 | -$382K | |
| 4 |
Jennison Associates
New York
|
-$344K |
| 5 |
Millennium Management
New York
|
-$243K |